108 related articles for article (PubMed ID: 1540944)
1. Inhibition of proliferation by retinoids, cytokines and their combination in four human transformed epithelial cell lines.
Bollag W; Peck R; Frey JR
Cancer Lett; 1992 Feb; 62(2):167-72. PubMed ID: 1540944
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative activity of retinoids, interferon alpha and their combination in five human transformed cell lines.
Frey JR; Peck R; Bollag W
Cancer Lett; 1991 May; 57(3):223-7. PubMed ID: 1827753
[TBL] [Abstract][Full Text] [Related]
3. Experimental basis of cancer combination chemotherapy with retinoids, cytokines, 1,25-dihydroxyvitamin D3, and analogs.
Bollag W
J Cell Biochem; 1994 Dec; 56(4):427-35. PubMed ID: 7890801
[TBL] [Abstract][Full Text] [Related]
4. Retinoids and interferon: a new promising combination?
Bollag W
Br J Haematol; 1991 Oct; 79 Suppl 1():87-91. PubMed ID: 1718390
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative and synergistic effect of interferon alpha-2a, retinoids and their association in established human cancer cell lines.
Toma S; Monteghirfo S; Tasso P; Nicolò G; Spadini N; Palumbo R; Molina F
Cancer Lett; 1994 Jul; 82(2):209-16. PubMed ID: 8050093
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of retinoid-induced differentiation of HL-60 and U937 cell lines by cytokines.
Peck R; Bollag W
Eur J Cancer; 1991; 27(1):53-7. PubMed ID: 1826443
[TBL] [Abstract][Full Text] [Related]
7. Regulation of proliferation of UM-SCV-1A and UM-SCV-6 vulvar carcinoma cells by cytokines.
Vihko KK; Seppänen M; Henttinen T; Punnonen J; Grénman S; Punnonen R
Cancer Immunol Immunother; 1997 Jan; 43(6):368-74. PubMed ID: 9067409
[TBL] [Abstract][Full Text] [Related]
8. Effects of retinoids and interferon-gamma on cultured breast cancer cells in comparison with tumor necrosis factor alpha.
Marth C; Zech J; Böck G; Mayer I; Daxenbichler G
Int J Cancer; 1987 Dec; 40(6):840-5. PubMed ID: 2826339
[TBL] [Abstract][Full Text] [Related]
9. Cancer combination chemotherapy with retinoids: experimental rationale.
Bollag W; Majewski S; Jablonska S
Leukemia; 1994 Sep; 8(9):1453-7. PubMed ID: 7522288
[TBL] [Abstract][Full Text] [Related]
10. Retinoids, interferon alpha, 1,25-dihydroxyvitamin D3 and their combination inhibit angiogenesis induced by non-HPV-harboring tumor cell lines. RAR alpha mediates the antiangiogenic effect of retinoids.
Majewski S; Marczak M; Szmurlo A; Jablonska S; Bollag W
Cancer Lett; 1995 Feb; 89(1):117-24. PubMed ID: 7533656
[TBL] [Abstract][Full Text] [Related]
11. Cancer combination chemotherapy with retinoids: experimental rationale.
Bollag W; Majewski S; Jablonska S
Leukemia; 1994; 8 Suppl 3():S11-5. PubMed ID: 7528863
[TBL] [Abstract][Full Text] [Related]
12. Retinoids inhibit human glioma cell proliferation and migration in primary cell cultures but not in established cell lines.
Bouterfa H; Picht T; Kess D; Herbold C; Noll E; Black PM; Roosen K; Tonn JC
Neurosurgery; 2000 Feb; 46(2):419-30. PubMed ID: 10690732
[TBL] [Abstract][Full Text] [Related]
13. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation.
Lotan R; Dawson MI; Zou CC; Jong L; Lotan D; Zou CP
Cancer Res; 1995 Jan; 55(2):232-6. PubMed ID: 7812950
[TBL] [Abstract][Full Text] [Related]
14. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
[TBL] [Abstract][Full Text] [Related]
15. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
Schneider SM; Offterdinger M; Huber H; Grunt TW
Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
[TBL] [Abstract][Full Text] [Related]
16. Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons.
Fanjul AN; Bouterfa H; Dawson M; Pfahl M
Cancer Res; 1996 Apr; 56(7):1571-7. PubMed ID: 8603404
[TBL] [Abstract][Full Text] [Related]
17. Activity of retinoic acid receptor-gamma selectively binding retinoids alone and in combination with interferon-gamma in breast cancer cell lines.
Widschwendter M; Daxenbichler G; Culig Z; Michel S; Zeimet AG; Mörtl MG; Widschwendter A; Marth C
Int J Cancer; 1997 May; 71(3):497-504. PubMed ID: 9139890
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R
Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460
[TBL] [Abstract][Full Text] [Related]
19. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.
Dawson MI; Chao WR; Pine P; Jong L; Hobbs PD; Rudd CK; Quick TC; Niles RM; Zhang XK; Lombardo A
Cancer Res; 1995 Oct; 55(19):4446-51. PubMed ID: 7671258
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
